Wednesday, June 10, 2015 2:25:33 PM
Sure there has been progress in the personnel front. But so far that hasn't helped in stopping the share price from tanking. And it doesn't guarantee FDA approval of the IND. I know many of you are emotionally attached to this stock but the trend of the falling PPS isn't good. Unless there is some type of significant news, expect the stock to continue to drop. It's not that hard to understand, especially for an OTC penny stock. I am just glad I didn't buy when I was planning to. I'll wait a bit. Maybe you can explain to me with all the changes, why the stock keeps going down? 15 might be the bottom but I'd rather chase with good news than be a bag holder. And if the science truly does work, this will be a very special stock.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
